| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ken Inada, Jun Ishigook. [Clozapine]. Nihon rinsho. Japanese journal of clinical medicine. vol 71. issue 4. 2013-09-25. PMID:23678599. |
clozapine is a drug used in the management of treatment-resistant schizophrenia. |
2013-09-25 |
2023-08-12 |
Not clear |
| Ken Inada, Jun Ishigook. [Clozapine]. Nihon rinsho. Japanese journal of clinical medicine. vol 71. issue 4. 2013-09-25. PMID:23678599. |
therefore, in japan, clozapine is approved for administration to only patients with treatment-resistant schizophrenia in whom treatment with other antipsychotic drugs was ineffective. |
2013-09-25 |
2023-08-12 |
Not clear |
| Minoru Takebayash. [Electroconvulsive therapy in schizophrenia]. Nihon rinsho. Japanese journal of clinical medicine. vol 71. issue 4. 2013-09-25. PMID:23678602. |
therefore, a combination of ect with pharmacotherapy including clozapine may be effective for the pharmacotherapy -resistant schizophrenia. |
2013-09-25 |
2023-08-12 |
Not clear |
| Marcela Horvitz-Lennon, Julie M Donohue, Judith R Lave, Margarita Alegría, Sharon-Lise T Norman. The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries. Psychiatric services (Washington, D.C.). vol 64. issue 3. 2013-09-19. PMID:23242347. |
effectiveness trials have confirmed the superiority of clozapine in schizophrenia treatment, but little is known about whether the drug's superiority holds across racial-ethnic groups. |
2013-09-19 |
2023-08-12 |
Not clear |
| Tariq Munshi, Mir Mazhar, Tariq Hassa. Clozapine reinitiation following a "red result" secondary to chemotherapy. Neuropsychiatric disease and treatment. vol 9. 2013-09-16. PMID:24039428. |
clinicians are reluctant to prescribe clozapine in view of its side-effect profile, despite its proven efficacy for managing treatment-resistant schizophrenia. |
2013-09-16 |
2023-08-12 |
Not clear |
| Michelle Wilson, John Brett Offenberge. Intermittent neutropenia and leucopenia unrelated to clozapine in a 12-year-old girl with schizophrenia. Journal of child and adolescent psychopharmacology. vol 23. issue 2. 2013-09-13. PMID:23480326. |
intermittent neutropenia and leucopenia unrelated to clozapine in a 12-year-old girl with schizophrenia. |
2013-09-13 |
2023-08-12 |
Not clear |
| Frederike Schirmbeck, Franziska Rausch, Susanne Englisch, Sarah Eifler, Christine Esslinger, Andreas Meyer-Lindenberg, Mathias Zin. Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study. Journal of psychopharmacology (Oxford, England). vol 27. issue 4. 2013-09-09. PMID:23095245. |
over 12 months, we followed-up 75 schizophrenia patients who were classified into two groups according to antipsychotic treatment: clozapine or olanzapine (group i) versus aripiprazole or amisulpride (group ii). |
2013-09-09 |
2023-08-12 |
Not clear |
| John Lally, Anne Gallagher, Emma Bainbridge, Gloria Avalos, Mohamed Ahmed, Colm McDonal. Increases in triglyceride levels are associated with clinical response to clozapine treatment. Journal of psychopharmacology (Oxford, England). vol 27. issue 4. 2013-09-09. PMID:23325369. |
in this prospective observational study, we examine associations between therapeutic response to clozapine in 49 patients with treatment-resistant schizophrenia and lipid dysregulation. |
2013-09-09 |
2023-08-12 |
Not clear |
| Domenico De Berardis, Nicola Serroni, Daniela Campanella, Luigi Olivieri, Stefano Marini, Francesco Saverio Moschetta, Giovanni Martinotti, Massimo Di Giannantoni. Safety and efficacy of combined clozapine-azathioprine treatment in a case of resistant schizophrenia associated with Behçet's disease: a 2-year follow-up. General hospital psychiatry. vol 35. issue 2. 2013-09-03. PMID:22819722. |
we here report on a 37-year-old man with bd and treatment-resistant schizophrenia who obtained an improvement following the introduction of clozapine in addition to azathioprine, without developing agranulocytosis or other severe adverse side effects during a 2-year follow-up. |
2013-09-03 |
2023-08-12 |
Not clear |
| Tomiki Sumiyosh. Antipsychotic treatments; focus on lurasidone. Frontiers in pharmacology. vol 4. 2013-08-29. PMID:23986702. |
the introduction of atypical antipsychotic drugs (aapds), or second-generation antipsychotics, with clozapine as the prototype, has largely changed the clinicians' attitudes toward the treatment of mental illnesses including, but not limited to schizophrenia. |
2013-08-29 |
2023-08-12 |
Not clear |
| Seema Varma, Delia Bishara, Frank M C Besag, David Taylo. Clozapine-related EEG changes and seizures: dose and plasma-level relationships. Therapeutic advances in psychopharmacology. vol 1. issue 2. 2013-08-28. PMID:23983927. |
clozapine is a widely used atypical antipsychotic with a unique effectiveness in treatment-resistant schizophrenia. |
2013-08-28 |
2023-08-12 |
Not clear |
| Stephen Bleakley, David Brown, David Taylo. Does clozapine cause or worsen obsessive compulsive symptoms? An analysis and literature review. Therapeutic advances in psychopharmacology. vol 1. issue 6. 2013-08-28. PMID:23983945. |
clozapine is the most effective antipsychotic in treatment-resistant schizophrenia but its use portends with a high burden of adverse reactions. |
2013-08-28 |
2023-08-12 |
Not clear |
| Poornima Chandrappa, Luk H. Case reports of patients with treatment-resistant schizophrenia and related psychotic disorders intolerant to clozapine responding to high doses of quetiapine. Therapeutic advances in psychopharmacology. vol 2. issue 5. 2013-08-28. PMID:23983977. |
case reports of patients with treatment-resistant schizophrenia and related psychotic disorders intolerant to clozapine responding to high doses of quetiapine. |
2013-08-28 |
2023-08-12 |
Not clear |
| Vyasa Immadisetty, Pradeep Agrawa. A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review. Therapeutic advances in psychopharmacology. vol 2. issue 6. 2013-08-28. PMID:23983982. |
a 58-year-old man treated with clozapine for treatment-resistant schizophrenia developed bilateral painful parotid swellings and hypersalivation. |
2013-08-28 |
2023-08-12 |
Not clear |
| John Lally, Colm McDonal. Dramatic weight loss associated with commencing clozapine. BMJ case reports. vol 2011. 2013-08-26. PMID:22674113. |
the authors report the case of a 44-year-old man with a long history of chronic enduring schizophrenia who experienced dramatic weight loss after commencing treatment with clozapine, an antipsychotic medication characteristically associated with the greatest degree of weight gain among medical treatments for schizophrenia. |
2013-08-26 |
2023-08-12 |
Not clear |
| Tin-May Li, Chih-Tan Chung, I-Hua Wei, Chih-Chia Huan. Low-dose clozapine exacerbates and then improves mood in a patient with schizophrenia and history of surgical removal of an intraventricular meningioma. Journal of clinical psychopharmacology. vol 32. issue 6. 2013-08-26. PMID:23131888. |
low-dose clozapine exacerbates and then improves mood in a patient with schizophrenia and history of surgical removal of an intraventricular meningioma. |
2013-08-26 |
2023-08-12 |
Not clear |
| Chao-Cheng Lin, Hsien-Jane Chiu, Jen-Yeu Chen, Ying-Jay Liou, Ying-Chieh Wang, Tzu-Ting Chen, Ya-Mei Ba. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. Journal of clinical psychopharmacology. vol 33. issue 2. 2013-08-26. PMID:23422395. |
switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. |
2013-08-26 |
2023-08-12 |
Not clear |
| Chao-Cheng Lin, Hsien-Jane Chiu, Jen-Yeu Chen, Ying-Jay Liou, Ying-Chieh Wang, Tzu-Ting Chen, Ya-Mei Ba. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study. Journal of clinical psychopharmacology. vol 33. issue 2. 2013-08-26. PMID:23422395. |
zotepine, an atypical antipsychotic with a pharmacologic profile similar to clozapine, was found to be an effective treatment for patients with treatment-resistant schizophrenia in japan. |
2013-08-26 |
2023-08-12 |
Not clear |
| R Gopalakrishnan, T P Subhalakshmi, A Kuruvilla, K S Jaco. Clozapine re-challenge under the cover of Filgrastim. Journal of postgraduate medicine. vol 59. issue 1. 2013-08-06. PMID:23525060. |
we report a case of a patient with treatment-resistant schizophrenia who developed neutropenia with clozapine as a result of which the drug was discontinued. |
2013-08-06 |
2023-08-12 |
Not clear |
| Gerhard Gross, Karsten Wicke, Karla U Dresche. Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia. Naunyn-Schmiedeberg's archives of pharmacology. vol 386. issue 2. 2013-07-30. PMID:23128852. |
despite considerable affinity for d(3) receptors, the second-generation antipsychotics clozapine, risperidone, and olanzapine when administered to patients with schizophrenia seem not to occupy d(3) receptors sufficiently to derive any conclusion on a d(3)-mediated therapeutic benefit. |
2013-07-30 |
2023-08-12 |
Not clear |